prohibition partners
prohibition partners · page 6
- Adult-Use
Europe’s ‘First Fully Compliant Adult-Use Cannabis Supply Chains’ Now Operational, More to Follow in 2024
The United States’ adult-use cannabis market, which is now active in 24 states following the recent addition of Ohio, was worth US$17bn last year.
- Data & Analysis
The Global Cannabis Testing Industry Could Be Worth up to $770m by 2027, New Report States
As the cannabis industry continues to expand and evolve at pace throughout the globe, product testing is becoming an increasingly vital subsector.
- Medical
Navigating the Belgian Medical Cannabis Landscape: Insights from “Principles of Clinical Cannabinology”
In the intricate landscape of medical cannabis, Belgium has established a regulated framework to govern the use of cannabis for medicinal purposes.
- Press releases
New Report Finds Most European Countries Are ‘Wilfully Ignorant’ to High Levels of Injustice in Policing and Criminal Enforcement of Adult Cannabis Use
A new report from a leading UK cannabis advisory company has highlighted how a failure to capture data related to race – when policing illicit adult cannabis use across Europe – risks adding to disproportionate outcomes for ethnic minorities that are apparent in countries like the UK.
- Uncategorized
Prohibition Partners Announces Strategic Partnership with the National Cannabis Industry Association (NCIA)
[London, 26/09/2023] – Prohibition Partners, a leading cannabis industry business media & data business, is pleased to announce a significant strategic partnership with the National Cannabis Industry Association (NCIA).
- Data & Analysis
Pharmaceutical Cannabis Players Are Driving Technological Innovation Across The Value Chain
The slow but steady march of pharmaceutical players into the cannabis industry has spurned a new period of technological innovation, bringing new techniques and technologies to every part of the cannabis value chain.
- Data & Analysis
Pharma Industry Showing ‘Growing Interest’ in Cannabis as M&A Activity Increases
Big pharma has so far been cautious of diving headfirst into the cannabis industry, despite the growing body of evidence surrounding its medical benefits.
- Cultivation
Is EU-GMP Certification Really Necessary For Cannabis Cultivators?
HELLENIC Dynamics, the first pureplay medical cannabis cultivator to launch on the London Stock Exchange (LSE), has signed a new supply deal with German distributor Demecan.
- CBD Market
15% Of European Consumers Have Tried CBD, But Industry Held Back By ‘High Turnover Rate’ Of Users
THE European CBD market is set to see a ‘massive influx’ of previous and new consumers to the market over the coming year, new data suggests.
- Adult-Use
Global Cannabis Stocks Significantly Underperformed In 2022, But Trend Expected To ‘Reverse’ In Near Future
THE global cannabis industry’s stocks have performed far worse than the general markets throughout 2022, with nearly US$30bn wiped off the value of the world’s largest 20 cannabis companies.
- Press releases
New Report Shows How Thailand Is Leading Asia In Cannabis Revolution
CANNABIS is undergoing a process of re-liberalisation in Asia, where the outdated and harmful drug control policies are receding in favour of more sensible, supportive and economically sound policies.
- Adult-Use
Key Points Of Germany’s Adult Use Legislation Proposals Leaked, Revealing Plans For No Importation Of Cannabis For Adult Use
THE key points of how Germany’s upcoming adult-use cannabis legalisation will look have been leaked this morning by the German press.
